-
Stocks with implied volatility below 30-day mean; HGSI C
-
Stocks with implied volatility below 30-day mean; BP HGSI C
-
Stocks with implied volatility below 30-day mean; BP C HGSI
-
Active equity option families in first 50-minutes of trading according to Track Data are: AAPL C HGSI NFLX BAC
-
Top 10 News Items 11/15-11/19: The General (GM) Is Back!, China Raises Reserve Requirement for 5th Time This Year, 'Merger Monday' - Literally!
-
Notable Analyst Rating Changes 11/17: AXL, DISCA, GTLS, GME Upgraded; NSC, KEY, HGSI, JASO Downgraded
-
Citi Downgrades Human Genome Sciences (HGSI) to Hold, Cuts Target
-
Cohen's SAC Capital 13F Highlights: New Positions in McMoRan, Regis, Raised Stakes in Genzyme, Hertz, Sprint, Lowered Stakes in Apple, Exxon Mobil
-
Active equity option families in first 30-minutes of trading according to Track Data are: CSCO C HGSI RIMM
-
Stocks with implied volatility below index mean range; C AIG HGSI
-
Citi Adds Human Genome (HGSI) to 'Top Picks Live' List; Time to Buy When No One Else Is
-
Citi Adds Celgene (CELG) and Human Genome Sciences (HGSI) to 'Top Picks Live' List
-
Stocks with implied volatility below index mean range; HGSI AIG C
-
Notable Analyst Rating Changes 04/01: ANN, FL, OCR, AYI Upgraded; RIMM, BLK, DWA, AIB Downgraded
-
Human Genome (HGSI) Closes 17.83M Common Offering
-
Human Genome Sciences (HGSI) Prices 15M Common Offering at $26.75/Share; Offering Increased from 12.5M Common
-
Citigroup Lifts Price Target on Human Genome Sciences (HGSI) to $38
-
Goldman Sachs Lifts Tgt on Human Genome Sciences (HGSI) to $30, Sees As Acquisition Candidate
-
Active equity option families in first 30 minutes of trading: HGSI, BAC, F, C
-
Notable Analyst Rating Changes 10/15: JPM, PCG, NVLS, PRX Upgrade; BJS, BHI, SCHW, AZ, TRV, LAZ Downgrade
-
Active equity option families according to Track Data are: C BAC MAR HGSI
-
Notable Analyst Rating Changes 8/4: HBC, HGSI, PKY, DISH, TLB Upgraded; HOLX, ATML, ABX, STEC, LAMR Downgraded
-
Human Genome Sciences (HGSI) Prices 23M Shares at $14
-
Human Genome Sciences (HGSI) to Offer 18M Shares
-
Analysts Still Jumping on Human Genome Sciences (HGSI) Bandwagon: 3 Upgrades Today
-
After Yesterday's 276% Rise, Human Genome Sciences (HGSI) Is Up Again!
-
After a Nearly 280% Surge In Human Genome Sciences (HGSI) Is There More Upside?
-
Citi & Lazard Capital Jump on Bandwagon - Upgrade Human Genome Sciences (HGSI)
-
After-Hours Movers 4/29: IMNY, GMCR, SKX, FSLR, HGSI, BARE Higher; SQNM, ISYS, JDSU, CAVM, NTRI, AXTI Lower
-
Morning Movers 1/12: Advanced Medical Optics (EYE) Surges On Buyout; Harley-Davidson (HOG) Lower on Downgrade
-
Morning Movers 12/08: Chesapeake Energy (CHK) Higher on Capex Cut; GM (GM) Up On Likely Short-Term Gov Aid
-
Pre-Open Movers 4/17: FUQI Intl (FUQI) Higher on Raised Guidance, Nokia (NOK) Lower on Results/Outlook
-
Citi Downgrades Human Genome Sciences (HGSI) to Hold
-
Notable Analyst Rating Changes 1/24: GILD, HGSI, Homebuilders Upgraded; BMY, EBAY, GOOG, THQI Downgraded

